Overview of the 2006 Food and Drug Admin
✍
Tina L. Pinto Slottow; Ron Waksman
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 155 KB
👁 1 views
## Abstract Drug‐eluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led